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Abstract
Introduction: Enlargement of a pre-existing intracranial aneurysm is a well-established risk factor of rupture. Excessive
low wall shear stress concomitant with turbulent flow in the dome of an aneurysm may contribute to progression and
rupture. However, how stress conditions regulate enlargement of a pre-existing aneurysm remains to be elucidated.
Results: Wall shear stress was calculated with 3D-computational fluid dynamics simulation using three cases of
unruptured intracranial aneurysm. The resulting value, 0.017 Pa at the dome, was much lower than that in the
parent artery. We loaded wall shear stress corresponding to the value and also turbulent flow to the primary
culture of endothelial cells. We then obtained gene expression profiles by RNA sequence analysis. RNA sequence
analysis detected hundreds of differentially expressed genes among groups. Gene ontology and pathway analysis
identified signaling related with cell division/proliferation as overrepresented in the low wall shear stress–loaded
group, which was further augmented by the addition of turbulent flow. Moreover, expression of some chemoattractants
for inflammatory cells, including MCP-1, was upregulated under low wall shear stress with concomitant turbulent flow.
We further examined the temporal sequence of expressions of factors identified in an in vitro study using a rat model. No
proliferative cells were detected, but MCP-1 expression was induced and sustained in the endothelial cell layer.
Conclusions: Low wall shear stress concomitant with turbulent flow contributes to sustained expression of MCP-1 in
endothelial cells and presumably plays a role in facilitating macrophage infiltration and exacerbating inflammation, which
leads to enlargement or rupture.
Introduction
As medical treatments have advanced, the outcomes for
patients with various diseases have greatly improved.
However, in cases of subarachnoid hemorrhage, this is
not necessarily true. Subarachnoid hemorrhage often
causes sudden death without a chance for therapeutic
intervention, even in young patients, and its prognosis is
still quite poor regardless of improvements in
neurocritical care [1]. Intracranial aneurysm (IA), histolog-
ically characterized as a lesion with disrupted internal elas-
tic lamina and excessive degeneration of media, is a major
cause of subarachnoid hemorrhage [2, 3]. Considering the
poor outcomes once after subarachnoid hemorrhage oc-
curs [1] and the high incidence of IA in the general popu-
lation [2], appropriate treatment to prevent rupture is
crucial. However, there is no practicable medical treatment
available for patients with IAs to prevent enlargement or
rupture. The primary reason underlying this reality is that
the detailed mechanisms regulating IA formation and pro-
gression remain to be elucidated.
Experimental studies using an animal model of IA
have clarified the crucial role of persistent inflammation,
presumably triggered by high wall shear stress (WSS)
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loaded on intracranial arterial walls at bifurcation sites
and maintained/amplified by the formation of a positive
feedback loop that includes the cyclooxygenase (COX)-
2-prostaglandin (PG) E2-EP2-NF-κB cascade in endothe-
lial cells (ECs) [4–6]. Computational fluid dynamic
(CFD) analyses of human intracranial artery or IA le-
sions have supported this notion because high WSS can
be detected at the prospective site of IA formation or
the neck portion of IAs [7, 8]. Because the pharmaco-
logical inhibition of pro-inflammatory factors or genetic
deletion of pro-inflammatory genes significantly sup-
presses not only the incidence but also the enlargement
of IAs [4, 5, 9–11], long-lasting inflammation in intra-
cranial arteries plays a role in both these steps. In terms
of inflammation, therefore, the initiation and enlarge-
ment/progression of IAs share the same machinery.
However, the hemodynamic status during these two
steps is completely opposite. In the dome of growing
IAs, the region of low WSS significantly overlaps with
that of the enlarging portion [12, 13], suggesting the role
of low WSS in the enlargement of IAs. Importantly, at
the rupture point of IAs, the presence of low WSS and
concomitant turbulent flow have also been demonstrated
[14, 15], although there is a controversy regarding WSS
status relating with the rupture of IAs [16]. However, the
contribution of low WSS with or without concomitant
turbulent flow loaded on the ECs of IA walls to enlarge-
ment and rupture remains to be elucidated. Considered
with the fact that the target of treatment is of course pre-
existing IAs and that a recent cohort study in Japan clearly
demonstrated the positive correlation of the size of IAs
with the annual risk of rupture [17], factors induced in
ECs under low WSS condition may be good candidates
for development of therapeutic drugs to prevent enlarge-
ment and presumably rupture of pre-existing IAs.
In the present study, we loaded WSS calculated from
human cases by three-dimensional (3D) computational
simulation on primary culture of ECs and examined the
change in gene expression profiles and the temporal se-
quence of their expression in lesions.
Materials and methods
Data acquisition
Usage of 3D-computational tomography angiography
(3D-CTA) data in the present study was approved by the
review committee of the National Hospital Organization,
Kyoto Medical Center in Kyoto, Japan.
Three patients with unruptured aneurysm were enrolled
in the present study. In order to calculate WSS acting on
the dome of human IAs and parent arteries, we employed
three patient-specific, anatomically realistic arterial geom-
etries of unruptured IAs. The geometries were segmented
precisely from the volume data set of 3D-CTA using the
Vascular Modeling Toolkit (VMTK) [18]. To apply CFD
technique to these geometries, we generated high-
quality computational meshes, including wall boundary-
fitted layers, which were necessary to capture the steep
velocity profiles near the wall boundary and to calculate
WSS accurately, using the Mixed-Element Grid Generator
in 3 Dimensions (MEGG3D) [19, 20]. A well-validated
CFD solver, OpenFOAM, was used to perform blood flow
analyses. In the CFD analyses, blood was treated as a
Newtonian fluid and the wall was assumed to be rigid. We
used patient-specific flow velocities measured with the
ultrasound Doppler technique as the inlet boundary con-
dition of the CFD analyses.
Primary culture of endothelial cells from human carotid
artery
The primary culture of ECs from human carotid artery
was purchased from Cell Applications (San Diego, CA,
USA). The characteristics of these cells were confirmed
to be compatible with those of ECs in some methods, in-
cluding immunohistochemistry [4].
Loading shear stress
The primary culture of ECs, cultured on gelatin-coated
glass slides, were loaded with a shear stress at 0.05 or 3.0
Pa according to the result from CFD analyses with a
custom-made apparatus, as previously described [21]. After
24 h of shear stress loading, the cells were harvested. In
addition, turbulent flow was loaded on ECs with a custom-
made apparatus, as previously reported [22].
RNA extraction and cap analysis of gene expression analysis
Using an RNeasy Plus Mini Kit (QIAGEN, Hilden,
Germany), total RNA was prepared from ECs loaded on
shear stress or kept in a static condition as a control; the
quality was checked by an RNA analyzer. RNA sequence-
based cap analysis of gene expression (CAGE) analysis,
which was conducted by the Genome Network Analysis
Support Facility (GeNAS) at RIKEN (http://www.osc.ri-
ken.jp/genas/), was employed to obtain the gene expres-
sion profile [23, 24]. Pathway and gene ontology (GO)
analyses were performed with the Platform for Drug Dis-
covery housed at the Data Analysis Center of the National
Institute of Genetics (http://cell-innovation.nig.ac.jp/wiki2/
tiki-index.php?page=5.+CAGE) using peak data obtained
by the CAGE analysis.
Quantitative real time PCR
Total RNA was prepared as described in the previous
section and reverse-transcribed into cDNA using the
High Capacity cDNA Reverse Transcription Kit (Life
Technologies Corporation, Carlsbad, CA). Then, quanti-
tative real time PCR (RT-PCR) was performed with the
SYBR Premix Ex Taq II (Takara, Shiga, Japan) and Real
Time System CFX96 (Bio-Rad Laboratories, Irvine, CA).
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β-actin was used as an internal control. For quantifica-
tion, the second derivative maximum method was used
for crossing point determination. Primer sets used are
listed in Table 1.
Rodent IA models, histological analysis, and
immunohistochemistry of induced IAs
All of the following experiments complied with the Na-
tional Institutes of Health Guide for the Care and Use of
Laboratory Animals and were approved by the Institu-
tional Animal Care and Use Committee of the Kyoto
University Graduate School of Medicine.
Sprague-Dawley rats were purchased from Japan SLC
(Shizuoka, Japan). To induce IA, male 7-week-old rats
were subjected to ligation of the left carotid artery and
ligation of the left renal artery under general anesthesia
by intraperitoneal injection of pentobarbital sodium (50
mg/kg). Animals were fed a special chow containing 8 %
sodium chloride and, in some experiments, 0.12 % 3-
aminopropionitrile (Tokyo Chemical Industry, Tokyo,
Japan), an inhibitor of lysyl oxidase that catalyzes cross-
linking of collagen and elastin. The procedure to induce
IAs (defined as “aneurysm induction”) was designed to
increase the local hemodynamic stress on the right bifur-
cation site of the anterior cerebral artery and olfactory
artery a contralateral side of carotid ligation [4, 25, 26].
For histological analyses, animals were deeply anesthe-
tized by intraperitoneal injection of a lethal dose of
pentobarbital sodium and transcardinally perfused with
a fixative, 4 % paraformaldehyde. Then, the circle of
Willis including IA lesion was dissected out and serial
frozen sections of 5-μm thickness were prepared. For
immunohistochemistry, after blocking with 3 % donkey
serum (Jackson ImmunoResearch, Baltimore, MD), the
sections were incubated with primary antibodies
followed by incubation with secondary antibodies conju-
gated with fluorescent dye (Jackson ImmunoResearch).
Finally, immunofluorescence images were acquired with
a confocal fluorescence microscope system (Lsm710;
Carl Zeiss Microscopy GmBH, Gottingen, Germany).
The following primary antibodies were used: mouse
monoclonal anti-smooth muscle alpha actin antibody
(#MS113; Thermo Scientific, Waltham, MA), goat poly-
clonal anti-MCP-1 antibody (#sc-1785; Santa Cruz Bio-
technology, Dallas, TX), goat polyclonal anti-CX3CL1
antibody (#AF537; R&D Systems, Minneapolis, MN).
Detection of proliferative cells in rat intracranial arteries
To detect proliferative cells in vivo, rats were given an
intraperitoneal injection of 5-ethynyl-2′-deoxyuridine
Table 1 List of primer sets used in the present study
Gene name Reference Sequence forward primer (5′→ 3′) reverse primer (5′→ 3′)
ACTB NM_001101.3 CAT ACT CCT GCT TGC TGA TCC GAT GCA GAA GGA GAT CAC TGC
CCL2 NM_002982.3 AGC TTC TTT GGG ACA CTT GC ATA GCA GCC ACC TTC ATT CC
CCNB NM_031966.3 GGA TCA GCT CCA TCT TCT GC TTT GGT TGA TAC TGC CTC TCC
CDCA7 NM_031942.3 GAA ACT AAG CGG TTG GAG AGG TTC TGG AGC ATC ACA GAA GG
CDC20 NM_001255.2 CAG AGC ACA CAT TCC AGA TGC GTT CCT CTG CAG ACA TTC ACC
CDK1 NM_001786.4 CTG GCC ACA CTT CAT TAT TGG GCA CCA TAT TTG CTG AAC TAG C
CXCL6 NM_002993.3 TAG TGG TCA AGA GAG GGT TCG GAG GGA TGA ATG CAG ATA AAG G
CX3CL1 NM_002996.3 CGT CAA AGG GAA CCT CTA ACC CTT GAC CAT TCT CCA CCT TCC
E2F1 NM_005225.2 CGT TGG TGA TGT CAT AGA TGC CAC TGA ATC TGA CCA CCA AGC
FANCI NM_001113378.1 TTT AAC AAG GTG TCC ACA CAG C CTC TTC TCA GGC AAC CCT ACC
HIST1H1D NM_005320.2 CTC CTT AGA AGC TGC CAC TGC TCC ACT TGC TCC TAC CAT TCC
HIST1H1E NM_005321.2 GCC TTC TTG TTG AGT TTG AAG G GAC GTG GAG AAG AAC AAC AGC
HIST1H2AH NM_080596.2 CTG GAT ATT GGG CAA GAC ACC ACA AGA AGA CCC GTA TCA TCC
HIST1H2BO NM_003527.4 GAG CTG GTG TAC TTG GTG ACG CTG GCG CAT TAC AAC AAG C
HIST1H2I NM_003525.1 ACT TGG AGC TGG TGT ACT TGG ACT TCC AGG GAG ATC CAA AGC
KIF11 NM_004523.3 CTG ATC AAG GAG ATG TTC ACG TGG AAC AGG ATC TGA AAC TGG
KIF15 NM_020242.1 TGA AGA AAG CTC CTT GTC AGC GAC CAA ACA GCA GGA AGA GC
MYBL2 NM_002466.3 GAG GCT GGA AGA GTT TGA AGG CTC TGG CTC TTG ACA TTG TGG
NOS3 NM_000603.4 GTC CAG GAA GAA GGT GAG AGC CAG TAG AGC AGC TGG AGA AGG
NUF21 NM_145697.2 CAC TTC CAA CTG ACA TGA AGG TGA AAG ATA CGG TCC AGA AGC
SELE NM_000450.2 GTC TTG GTC TCT TCA CCT TTG C AAA GAC TCA GTG TTC CCT TTC C
VCAM1 NM_001078.3 ACT TTG ACT TCT TGC TCA CAG C CTG TGC AAA TCC TTG ATA CTG C
Aoki et al. Acta Neuropathologica Communications  (2016) 4:48 Page 3 of 14
(EdU, 80 mg/kg) and, after 24 h, a specimen of intracra-
nial arteries was prepared as described above. EdU inter-
calated in genome was detected and visualized by click
reaction using Alexa488-conjugated azide according to
the manufacturer’s instruction (Click-iT EdU Imaging
Kits, Life Technologies).
Statistics
Data are shown in mean ± SEM. Statistical comparisons
between more than two groups were conducted using
the Kruskal-Wallis test followed by post-hoc Dunn’s test.
P less than 0.05 was considered statistically significant.
Results
Calculation of wall shear stress
Three patients with unruptured IAs were enrolled in the
present study. WSS loaded on the dome of each IA and
the corresponding parent artery was calculated by CFD
analysis (Fig. 1). Mean WSS calculated from the three
cases were 0.017 Pa (±0.0027, n = 3) at the minimum
value in the dome of IAs or 6.50 Pa (±0.66, n = 3) in the
neck portion of IAs, respectively. Notably, WSS in the
dome of IAs were strikingly lower compared with those
in the parent artery (3.0 Pa), which is consistent with
previous reports [12, 13].
Change of gene expression profile
To verify the effect of each WSS on gene expression, a
primary culture of ECs from human carotid artery was
cultured and shear stress corresponding to the value (3.0
Pa, 0.05 Pa) obtained in CFD was loaded on these cells
for 24 h. In addition, because some studies have demon-
strated the presence of turbulent flow in addition to low
WSS at the rupture point of IAs in human cases [14,
15], cultured ECs were loaded with the turbulent flow in
combination with low WSS. Then, after the quality of
purified RNA from the stimulated cells was confirmed
by RNA analyzer (RIN > 9.50), the gene expression pro-
file was obtained by RNA sequence–based CAGE ana-
lyses. The read count, which was successfully mapped to
the reference genome using the MOIRAI workflow sys-
tem [27], was around 10,000,000, enough for further
analyses (Table 2). Then, profiling differentially express-
ing genes (peaks in RNA sequence mapped to the refer-
ence genome) between experimental groups was
obtained by a pipeline, RECLU [28]. Here, the RECLU
pipeline extracted two types of clusters, top peaks and
bottom ones [28]. Briefly, top peaks or bottom ones rep-
resent the narrowest or broadest reproducible peaks in
an RNA sequence [28]. Upregulated or downregulated
peaks in a 0.05 Pa–loaded group compared with those in
a 3.0 Pa–loaded group were identified; the total number
was around 300 (Table 3). In another comparison, differ-
entially expressed genes were also identified (Table 3).
For the GO analyses, GO terms related with cell div-
ision/proliferation, such as nucleosome, mitotic cell
cycle, and DNA replication, were highly overrepresented
in the 0.05 Pa + turbulent flow–loaded group compared
with the 3.0 Pa-loaded group (Table 4). Indeed, overex-
pressed genes in the 0.05 Pa + turbulent flow–loaded
group included those related with cell division and pro-
liferation (Table 5), which is consistent with a previous
study that turbulent flow enhances proliferation of ECs
[29]. Underrepresented terms in this comparison in-
cluded IL-33 receptor activity and IL-1 receptor activity,
but the p value was much less compared with that of the
overrepresented terms (Table 4). In comparisons be-
tween the 0.05 Pa-loaded group and the 3.0 Pa-loaded
group or 0.05 Pa + turbulent flow–loaded group and
0.05 Pa-loaded group, GO terms related with cell div-
ision/proliferation, such as mitosis, were flagged as over-
represented in the 0.05 Pa-loaded (Table 6) or 0.05 Pa +
turbulent flow–loaded group (Table 7), respectively, sug-
gesting that cell division/proliferation was enhanced in a
low WSS condition and further amplified by turbulent
flow. In pathway analyses, biological processes consist-
ently related with cell division/proliferation, such as telo-
mere maintenance, mitotic cell cycle, and DNA
replication, were overrepresented in a set of genes from
the low WSS-loaded group compared with that of the
3.0 Pa-loaded group (Table 8).
In addition to genes located at the head of the list,
which included many genes related with cell division or
proliferation (Table 5), upregulated genes in the 0.05 Pa
Fig. 1 CFD analysis of intracranial aneurysm from three human patients. The value of wall shear stress (WSS) is indicated in the color phase
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or 0.05 Pa + turbulent flow–loaded group included che-
moattractants or adhesion molecules for inflammatory
cells. Next, we focused on these chemoattractants and
adhesion molecules because inflammatory cells, espe-
cially macrophages, play a crucial role in IA formation/
progression [10, 11, 30]. In the low WSS condition (0.05
Pa), expression of CX3CL1, a chemoattractant for mono-
cytes, and VCAM-1 were induced compared with the
3.0 Pa-loaded group (Table 9). Presence of turbulent
flow concomitant with low WSS further augmented the
expression of chemoattractants and adhesion molecules
such as CCL2 (gene for MCP-1), a chemoattractant for
macrophages, CXCL6, a chemoattractant for granulo-
cytes, and SELE (gene for E-selectin) (Table 9). These re-
sults suggest that turbulent flow with concomitant low
WSS induces chemoattractants and adhesion molecules
for inflammatory cells in ECs that in turn recruit cells in
lesions to evoke inflammation.
RT-PCR analyses of genes differentially expressed under
each WSS condition
To confirm results of the gene expression profile ob-
tained by the RNA sequence–based CAGE analysis, we
examined the expression of selected genes by RT-PCR
and found that the results could be reproduced (Fig. 2).
For example, genes related to cell proliferation/division,
such as histone subunit genes (HIST1HID, etc.), cyclin or
cyclin-dependent kinase (CDK1, CCNB), transcription fac-
tor regulating cell cycle (E2F1), genes regulating cell div-
ision (CDC20, CDCA7), the nuclear protein promoting
cell cycle (MYBL2), gene regulating chromatin segregation
(NUF2), kinesins that transport materials in cytoplasm
(KIF11, KIF15), or gene encoding protein stabilizing DNA
(FANCI) were induced in ECs loaded on low WSS (Fig. 2).
Interestingly, NOS3 (eNOS) expression was downregu-
lated under low WSS conditions in RT-PCR (Fig. 2), sug-
gesting that there is a dysfunction of ECs in this WSS
condition, as demonstrated by previous studies in which
Table 2 Read count obtained in RNA-sequence-based CAGE
analysis
sample No. Mapped Read Count rRNA read count
0.05Pa 1 11,216,634 2,265,251
2 8,936,578 2,108,157
3.0Pa 1 11,293,958 1,776,765
2 9,160,492 2,264,215
0.05Pa + TF 1 6,765,681 1,171,547
2 9,547,702 1,795,395
TF turbulent flow
Table 3 Number of differentially expressed peaks between each
comparison









3.0Pa vs. 0.05Pa 314 331 261 385
3.0Pa vs. 0.05Pa + TF 604 562 496 395
0.05Pa vs. 0.05Pa + TF 78 214 74 148
TF turbulent flow
Table 4 GO term analysis of differentially expressing genes
between 3.0Pa-loaded and 0.05Pa + turbulent flow-loaded group
Over-presented term in 0.05Pa + turbulent flow-loaded group
Accession Term P-value FDR
GO:0000786 nucleosome 7.7E-54 3.0E-51
GO:0006334 nucleosome assembly 6.4E-53 1.3E-50
GO:0000278 mitotic cell cycle 3.8E-26 5.1E-24
GO:0007067 mitosis 9.7E-26 9.6E-24
GO:0046982 protein heterodimerization activity 9.7E-24 7.7E-22
GO:0005654 nucleoplasm 5.6E-19 3.7E-17
GO:0060968 regulation of gene silencing 8.7E-15 4.7E-13
GO:0003677 DNA binding 9.5E-15 4.7E-13
GO:0005819 spindle 8.5E-14 3.7E-12
GO:0000775 chromosome, centromeric region 3.5E-13 1.4E-11




GO:0034080 CENP-A containing nucleosome
assembly at centromere
5.9E-12 1.8E-10
GO:0007059 chromosome segregation 1.6E-11 4.5E-10
GO:0006260 DNA replication 1.1E-10 2.9E-09
GO:0030496 midbody 1.6E-10 3.9E-09
GO:0031536 positive regulation of exit from mitosis 2.1E-10 4.8E-09
GO:0000922 spindle pole 3.6E-10 7.8E-09
GO:0005876 spindle microtubule 1.9E-09 4.0E-08
GO:0006281 DNA repair 2.5E-09 5.0E-08
Under-presented term in 0.05Pa + turbulent flow-loaded group
Accession Term P-value FDR
GO:0002113 interleukin-33 binding 2.9E-07 5.9E-05
GO:0002114 interleukin-33 receptor activity 2.9E-07 5.9E-05
GO:0043032 positive regulation of macrophage
activation
7.9E-07 1.1E-04
GO:0090197 positive regulation of chemokine
secretion
1.0E-06 1.1E-04
GO:0004908 interleukin-1 receptor activity 1.5E-06 1.2E-04
GO:0002826 negative regulation of T-helper
1 type immune response
1.7E-06 1.2E-04
GO:0032754 positive regulation of interleukin-
5 production
3.6E-05 2.1E-03
GO:0070698 type I activin receptor binding 5.9E-05 3.0E-03
GO:0071310 cellular response to organic substance 1.1E-04 4.9E-03
GO:0030617 inhibitory cytoplasmic mediator activity 1.2E-04 4.9E-03
FDR false discovery rate
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there was a loss of gap junction during IA formation [31]
or a decrease of eNOS staining in the dome of IAs [32].
We also confirmed that the genes for chemoattractants
and adhesion molecules, VCAM1, CX3CL1, SELE, CCL2,
CXCL6, were induced under low WSS or low WSS with
concomitant turbulent flow condition (Fig. 2) during the
RNA sequence analysis (Table 9). Again, we noted the re-
markable contribution of turbulent flow in addition to
concomitant low WSS to induction of these genes.
Proliferative status of intracranial arterial walls during IA
formation
In response to the results of an in vitro study that showed
pathways related with proliferation of ECs are
overrepresented under low WSS and concomitant turbu-
lent flow, we examined the proliferation of cells in intra-
cranial arterial walls in vivo. In this experiment, we used
Edu, which was intercalated in the genome during replica-
tion of proliferative cells as an alternative of thymidine, to
detect proliferative cells in rat tissue. In the small intes-
tine, which was used as a positive control, proliferative
cells incorporated with EdU were detected as Alexa488-
positive cells in all rats that were examined (Fig. 3a), con-
firming the proper procedure to detect proliferative cells
in vivo. In intracranial arterial walls before and after IA in-
duction, a small number of Alexa488-positive proliferative
cells were identified, but no signaling was detectable in
the endothelial cell layer (Fig. 3b and c), suggesting that
ECs in intracranial arteries do not actively proliferate.
Temporal sequence of MCP-1 and CXCL3 expression in IA
lesions in vivo
To verify the in vivo relevance of our in vitro study, we ex-
amined the temporal sequence of MCP-1 and CX3CL1
expression in the rat IA model. We selected these two
molecules because they could recruit macrophages, which
Table 5 List of over-expressed genes in 0.05Pa + turbulent flow-






PRND ENST00000305817 5.780 6.90E-14 BOTTOM
LTB ENST00000429299 6.170 3.80E-10 TOP
KIF15 ENST00000438321 6.110 8.80E-10 TOP
KIF20A ENST00000508792 8.290 1.40E-09 TOP
CENPA ENST00000233505 6.020 1.60E-09 TOP
NCAPH ENST00000240423 7.770 1.80E-07 TOP
KCNAB1 ENST00000389634 7.430 4.60E-06 TOP
LRRC17 ENST00000498487 7.270 6.00E-06 TOP
ASPM ENST00000294732 7.040 4.00E-05 TOP
CDC45 ENST00000404724 6.890 0.00011 TOP
RP11-322E11.5 ENST00000593122 6.770 0.00021 TOP
HIST1H2AH ENST00000377459 6.710 0.00026 TOP
SPC24 ENST00000423327 6.830 0.0004 TOP
FAM64A ENST00000572447 6.510 0.0018 TOP
MCM7 ENST00000489841 6.360 0.0029 TOP
HIST1H1B ENST00000331442 6.100 0.0047 BOTTOM
DAB2IP ENST00000436835 6.100 0.0047 BOTTOM
RRM2 ENST00000459969 6.190 0.0052 TOP
DEPDC1B ENST00000453022 6.100 0.0082 TOP
EXO1 ENST00000423131 6.100 0.009 TOP
PDLIM3 ENST00000284770 6.000 0.01 TOP
CENPM ENST00000402420 6.000 0.015 TOP
PAK1 ENST00000528592 6.000 0.015 TOP
ME3 ENST00000526834 5.900 0.015 TOP
HIST1H2BI ENST00000377733 5.780 0.017 BOTTOM
TTK ENST00000509313 5.900 0.019 TOP
ITM2B ENST00000463839 6.100 0.02 TOP
ERCC6L ENST00000373657 5.790 0.024 TOP
KIT ENST00000514582 5.790 0.024 TOP
CENPA ENST00000419525 5.900 0.025 TOP
Table 6 Over-presented term in 0.05Pa -loaded group
compared with 3.0Pa-loaded group in GO term analysis
Accession Term P-value FDR
GO:0000786 nucleosome 3.5E-27 4.9E-25
GO:0006334 nucleosome assembly 1.5E-24 1.1E-22
GO:0046982 protein heterodimerization activity 1.3E-14 6.0E-13
GO:0060968 regulation of gene silencing 4.9E-10 1.7E-08
GO:0000278 mitotic cell cycle 3.4E-09 9.6E-08
GO:0003677 DNA binding 4.7E-09 1.1E-07
GO:0005654 nucleoplasm 7.3E-09 1.5E-07
GO:0031145 anaphase-promoting complex-
dependent proteasomal ubiquitin-
dependent protein catabolic process
1.9E-06 3.3E-05
GO:0006260 DNA replication 1.3E-05 1.7E-04
GO:0010994 free ubiquitin chain polymerization 1.3E-05 1.7E-04
GO:0000083 regulation of transcription involved in
G1/S transition of mitotic cell cycle
1.4E-05 1.7E-04
GO:0051437 positive regulation of ubiquitin-protein
ligase activity involved in mitotic cell cycle
2.8E-05 3.3E-04
GO:0051439 regulation of ubiquitin-protein ligase
activity involved in mitotic cell cycle
3.3E-05 3.4E-04
GO:0043565 sequence-specific DNA binding 3.4E-05 3.4E-04
GO:0031536 positive regulation of exit from mitosis 4.6E-05 4.3E-04
GO:0007067 mitosis 5.4E-05 4.7E-04
GO:0008054 cyclin catabolic process 6.6E-05 5.4E-04
GO:0000281 mitotic cytokinesis 7.2E-05 5.6E-04
GO:0005634 nucleus 8.0E-05 5.9E-04
GO:0034501 protein localization to kinetochore 1.0E-04 7.1E-04
FDR false discovery rate
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serve as major inflammatory cells in lesions both in hu-
man and animal models [33, 34]. In addition, MCP-1–me-
diated recruitment of macrophages plays a crucial role in
IA formation/progression via the secretion of a variety of
pro-inflammatory factors because genetic deletion or
inhibition of MCP-1 has been shown to almost completely
suppress IA formation in animal models [11, 30].
MCP-1 expression was only weakly detected in ECs of
intracranial arteries before induction (Fig. 4a and b). Its
intensity in immunostaining increased and spread to ad-
ventitia of arterial walls after IA induction, which was
consistent with our previous study [30]. Importantly, ex-
pression of MCP-1 in ECs of IA walls was sustained, not
decreased, during IA formation (Fig. 4a and b), suggest-
ing the in vivo relevance of in vitro study.
In the case of CX3CL1, expression was persistently de-
tectable in intracranial arteries, including endothelial cell
layer, from day 0 to day 21 of IA induction (Fig. 4c).
However, the signal intensity did not change during IA
formation (Fig. 4c), which was consistent with our previ-
ous study of the gene expression profile of ECs from IA
lesions [35], indicating the independence of CX3CL1 in
IA formation.
Discussion
Recent studies have provided experimental evidence that
long-lasting inflammatory responses in intracranial ar-
teries play a crucial role in IA formation [10]. During
this process, MCP-1-mediated macrophage recruitment
and macrophage-evoked inflammation are critical for IA
formation because of the genetic deletion of MCP-1, in-
hibition of MCP-1 by a dominant negative form (7-ND),
or pharmacological depletion of macrophages that re-
markably suppress IA formation [11, 30]. MCP-1 is in-
duced in ECs in intracranial arteries under a high WSS
condition loaded at an early stage of IA formation [30].
Although shear stress dramatically changes during IA
progression, from high WSS at an early stage [7, 8] to
low WSS, sometimes with turbulent flow, at a later stage
Table 7 Over-presented term in 0.05Pa + turbulent flow-loaded
group compared with 0.05Pa-loaded group in GO term analysis
Accession Term P-value FDR
GO:0000775 chromosome, centromeric region 9.3E-07 3.6E-05
GO:0007067 mitosis 9.9E-07 3.6E-05
GO:0000786 nucleosome 1.9E-06 4.7E-05
GO:0000278 mitotic cell cycle 8.4E-06 1.5E-04
GO:0031536 positive regulation of exit from mitosis 1.2E-05 1.7E-04
GO:0030496 midbody 1.8E-05 2.1E-04
GO:0006334 nucleosome assembly 2.3E-05 2.4E-04
GO:0000079 regulation of cyclin-dependent
protein kinase activity
6.5E-05 5.9E-04
GO:0007059 chromosome segregation 1.4E-04 1.2E-03
GO:0051382 kinetochore assembly 2.0E-04 1.5E-03
GO:0000070 mitotic sister chromatid segregation 2.8E-04 1.9E-03
GO:0000922 spindle pole 3.2E-04 1.9E-03
GO:0051301 cell division 3.7E-04 2.1E-03
GO:0000086 G2/M transition of mitotic cell cycle 8.6E-04 4.5E-03
GO:0007094 mitotic spindle assembly checkpoint 9.3E-04 4.5E-03
GO:0005164 tumor necrosis factor receptor binding 1.3E-03 6.0E-03
GO:0000777 condensed chromosome kinetochore 2.9E-03 1.2E-02
GO:0007165 signal transduction 3.8E-03 1.5E-02
GO:0046982 protein heterodimerization activity 3.9E-03 1.5E-02
GO:0000910 cytokinesis 4.1E-03 1.5E-02
FDR false discovery rate
Table 8 Over-represented pathways in 0.05Pa-loaded or 0.05Pa + turbulent flow-loaded group compared with 3.0Pa-loaded group
Comparison Peaks REACTOME ID Pathway P-value FDR
3.0Pa < 0.05Pa + TF Top peaks REACT_7970 Telomere Maintenance 7.53E-12 1.36E-10
REACT_8017 APC-Cdc20 mediated degradation of Nek2A 3.74E-03 2.32E-02
REACT_152 Cell Cycle, Mitotic 3.86E-03 2.32E-02
Bottom peaks REACT_7970 Telomere Maintenance 2.67E-14 4.01E-13
REACT_152 Cell Cycle, Mitotic 8.97E-03 6.73E-02
3.0Pa < 0.05Pa Top peaks REACT_7970 Telomere Maintenance 5.21E-08 5.21E-07
REACT_383 DNA Replication 2.24E-02 1.12E-01
REACT_1538 Cell Cycle Checkpoints 8.86E-02 2.48E-01
REACT_6850 Cdc20:Phospho-APC/C mediated degradation of Cyclin A 1.20E-01 2.48E-01
REACT_152 Cell Cycle, Mitotic 1.35E-01 2.48E-01
REACT_8017 APC-Cdc20 mediated degradation of Nek2A 1.49E-01 2.48E-01
Bottom peaks REACT_7970 Telomere Maintenance 1.16E-06 6.96E-06
REACT_152 Cell Cycle, Mitotic 1.03E-02 3.09E-02
REACT_383 DNA Replication 3.15E-02 6.30E-02
FDR false discovery rate
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[12–14], MCP-1 expression is sustained in ECs of IA le-
sions induced in a rat model both by immunostaining
[30] and RT-PCR analysis [35]. Consistently, MCP-1 ex-
pression is also detected in ECs of human IA walls [30]
in which low WSS is present. The current experiment
addressed this issue and provided experimental evidence
linking low WSS with concomitant turbulent flow and
MCP-1 expression in ECs of IA walls.
MCP-1 expression under a low WSS stress condition
is presumably critical for macrophage infiltration in
pathological conditions, as observed in IA walls, to ex-
acerbate inflammatory responses leading to progression
of IAs. This is due to the fact that a low WSS condition
facilitates adhesion of macrophages to ECs expressing
MCP-1, but a high WSS condition interferes with adhe-
sion. Furthermore, the present study again highlights the
importance of MCP-1 over the entire period of IA for-
mation/progression because induction of another
chemoattractant for macrophages, CX3CL1, is not
obvious during IA formation. Among genes induced
under a low WSS condition in ECs, VCAM-1 [5] and E-
selectin [36] induction in IA lesions, including ECs in
the dome of a rat model, have been reported, suggesting
the in vivo relevance of the present study. Consistent
with our RNA-sequence and RT-PCR analyses that
VCAM-1 can be induced under a low WSS condition,
VCAM-1 expression in ECs in the dome of IAs induced
in a rat model has been demonstrated [5]. However, the
contribution of this molecule to IA formation and pro-
gression is not clear. E-selectin can also be induced in
ECs in the dome of IAs during IA formation [36]. How-
ever, because inhibition of E-selectin expression by ci-
metidine failed to suppress infiltration of macrophages
in lesion and IA formation [36], the contribution of E-
selectin to IA formation could be interpreted as nega-
tive. Intriguingly, the present study clearly demonstrated
the importance of concomitant turbulent flow with low
WSS in the exacerbation of macrophage infiltration via
Table 9 Up-regulation of chemoattractants and adhesion molecules for inflammatory cells in 0.05Pa or 0.05Pa + turbulent flow-loaded group
3.0Pa < 0.05Pa
Symbol Gene Accession Start End Log Fold Change P-value Peaks
CX3CL1 ENST00000006053 57406348 57406458 3.20 2.9E-03 BOTTOM
CX3CL1 ENST00000563383 57406400 57406402 3.69 2.1E-02 TOP
VCAM1 ENST00000370119 101185296 101185298 4.89 1.7E-03 TOP
VCAM1 ENST00000370119 101185284 101185300 4.37 6.9E-06 BOTTOM
0.05Pa < 0.05Pa + turbulent flow
Symbol Gene Accession Start End Log Fold Change P-value Peaks
CCL2 ENST00000225831 32582302 32582304 2.27 2.4E-04 TOP
CCL2 ENST00000225831 32582222 32582386 2.06 1.2E-06 BOTTOM
CXCL1 ENST00000509101 74735046 74735111 1.45 1.2E-02 BOTTOM
CXCL6 ENST00000515050 74702302 74702396 1.87 2.6E-02 BOTTOM
ICAM1 ENST00000423829 10381756 10381818 1.39 7.5E-03 BOTTOM
ICAM2 ENST00000581417 62084077 62084249 1.38 5.5E-03 BOTTOM
SELE ENST00000367779 169703219 169703222 2.95 7.0E-03 BOTTOM
VCAM1 ENST00000370119 101185275 101185302 1.33 2.6E-02 BOTTOM
3.0Pa < 0.05Pa + turbulent flow
Symbol Gene Accession Start End Log Fold Change P-value Peaks
CCL2 ENST00000225831 32582302 32582304 2.08 2.6E-03 TOP
CCL2 ENST00000225831 32582222 32582386 1.94 4.4E-04 BOTTOM
CCL2 ENST00000225831 32582222 32582224 2.15 4.5E-02 TOP
CX3CL1 ENST00000563383 57406400 57406402 2.19 4.7E-04 TOP
CX3CL1 ENST00000006053 57406348 57406402 2.03 1.7E-04 BOTTOM
CXCL11 ENST00000306621 76957183 76957237 2.89 1.4E-02 TOP
CXCL6 ENST00000515050 74702302 74702396 2.11 1.6E-02 BOTTOM
SELE ENST00000367779 169703220 169703222 3.69 1.5E-02 TOP
SELE ENST00000367779 169703219 169703222 2.94 2.8E-03 BOTTOM
VCAM1 ENST00000370119 101185275 101185302 1.33 2.6E-02 BOTTOM
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Fig. 2 Induction of genes in cultured endothelial cells (ECs) loaded on low WSS and turbulent flow. RNA was purified from cultured ECs loaded on 3.0
Pa, 0.05 Pa, or 0.05 Pa with turbulent flow (TF), and gene expressions were analyzed by RT-PCR analysis. All bars indicate mean ± SEM (n = 3). *p < 0.05
compared with 3.0 Pa-loaded group
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MCP-1 induction. Since the media of IA walls becomes
gradually thinner and smooth muscle cells in media are
shed during IA progression, these histopathological
changes of IA walls and MCP-1 induction under a low
WSS condition remarkably facilitates macrophage infil-
tration and the resultant exacerbation of inflammation
Fig. 3 Detection of proliferative cells in intracranial aneurysm lesions of rat. a, Proliferative cells in the small intestine of rats after intraperitoneal
injection of EdU (80mg/kg) were detected by click reaction (green color). Merged images with nuclear staining by DAPI are shown. Magnified
images are shown in the lower panels. Scale bar = 50μm. b and c, Proliferative cells in intracranial arterial walls of rats before (day 0, b) or after
(day 28, c) aneurysm induction were labeled after intraperitoneal injection of EdU. Immunostaining for α-smooth muscle actin (SMA) is shown to
visualize the arterial walls. Scale bar = 50μm
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Fig. 4 (See legend on next page.)
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and tissue destruction that presumably leads to rupture
of IAs. Indeed, massive macrophage infiltration of le-
sions has been reported in ruptured human IAs, but not
in unruptured ones, suggesting the role of macrophages
in the rupture of IAs. However, the rupture of IAs and
resultant inflammatory response itself may greatly in-
crease macrophage infiltration [37–39]. This hypothesis
goes hand-in-hand with the observation that turbulent
flow with low WSS can be detected at the rupture point
of IAs [14, 15], although contribution of abnormally high
WSS to the rupture of IAs is also presumed [16].
The present study includes several limitations. First,
there are potential limitations related to CFD. Specific-
ally, blood was treated as a Newtonian fluid and the wall
was assumed to be rigid in our CFD simulations. These
simplified properties might lead to a different state com-
pared with the in vivo state. However, the effect of a
non-Newtonian property on large artery hemodynamics
is believed to be small [40, 41]. In addition, it has been
reported that the overall feature of WSS distribution
does not considerably change when incorporating wall
deformation [42]. Thus, our CFD simulations provide a
reasonable WSS approximation of the in vivo state. An-
other limitation is that our sample size was small (3
cases of IA). We infer that the present low-WSS charac-
teristics in the dome are consistent among clinical cases,
as demonstrated by previous studies [12, 13, 43]. How-
ever, future studies will have to allow for more realistic
estimation of WSS, considering the wide range of geom-
etries that intracranial aneurysms can have. The IA rat
model used in the present study also has some intrinsic
limitations. IAs induced in a rat model are not saccular
with a narrow neck, but rather have a mountain-like
shape with a wide neck. Further, this model does not
allow for assessment of enlargement in the same animal
due to the small size of the lesions nor rupture because
of low incidence of spontaneous rupture [25]. Therefore,
we exclusively analyzed the enlargement of IAs in animal
models, and from this reference point we have provided
evidence geared toward developing therapeutic drugs to
prevent the enlargement of IAs. Here, because statins
suppressed enlargement of IAs in a rat model [44–46]
and usage of this class of drugs reduced the relative risk
of subarachnoid hemorrhage in a Japanese case-control
study [47], some drugs preventing progression of IAs in
animal models should be considered for human IAs to
prevent rupture. However, because approximately one
third of human IAs rupture but the remaining never
rupture [48], there may be different pathological pro-
cesses at work. In addition, we used primary culture of ECs
from the carotid artery, which is an extra-cranial artery, be-
cause we could not obtain ECs from human intracranial ar-
tery. Differences in the origins of ECs may influence results
and, therefore, we need to pay careful attention when ana-
lyzing data. One final major limitation of the present study
is that we could not reconstitute whole arterial walls, espe-
cially the physical or chemical interaction with adjacent
cells or structures such as medial smooth muscle cells or
internal elastic lamina. Indeed, turbulent flow concomitant
with low WSS greatly activates proliferation of ECs in vitro,
but not in IA walls in vivo. To examine the detailed inter-
action of hemodynamic forces with arterial walls, including
ECs leading to pathological situations, organ culture using
whole arterial walls may be necessary.
Conclusions
In the present study, we used primary culture of ECs
loaded on shear stress, RNA sequencing of these cells, bio-
informatic analysis of RNA-sequencing data, and verifica-
tion of results from in vitro data using a rat model of IAs.
These techniques showed that low wall shear stress with
concomitant turbulent flow induced expressions of chemo-
attractant and adhesion molecules for macrophages such
as MCP-1 in endothelial cells, which could be the mechan-
ism behind sustained macrophage infiltration during IA
progression and presumably rupture. In other words, we
have clarified that MCP-1 expression is sustained during
IA formation/progression independent of flow condition.
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